Back to RecallTracker
Health Canada Health products

Importation of US-Labelled Ketamine Hydrochloride for Injection due to Potential Shortage of Canadian-labelled Ketamine

Issued May 6, 2020
Issue
There is an unprecedented demand for ketamine hydrochloride injection, in Canada as a result of the COVID-19 pandemic. Given the medical necessity of this product, Health Canada has added US-labelled Ketamine Hydrochloride 500 mg/5 mL ( 100 mg/mL concentration ) in a 5 mL vial to the List of Drugs for Exceptional Importation and Sale in accordance with the Interim Order. Ketamine hydrochloride is a rapid-acting, nonbarbiturate general anesthetic and the 100 mg/mL concentration is not currently authorized for use in Canada; however, Health Canada has permitted the exceptional importation and sale of this US-labelled product to mitigate shortages in Canada.
Hazard description
Product safety